| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/25/2008 | US7348317 Aqueous compositions containing metronidazole |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | US7348016 Self-reversible reverse microlatex, process for preparing the same and cosmetic and industrial uses thereof |
| 03/25/2008 | US7347850 Adhesion barriers applicable by minimally invasive surgery and methods of use thereof |
| 03/25/2008 | US7347199 Pressurised metered dose inhalers (MDI) |
| 03/25/2008 | CA2432432C Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2333145C Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug |
| 03/25/2008 | CA2327522C Incorporation of active substances in carrier matrixes |
| 03/25/2008 | CA2319217C Pharmaceutical compositions |
| 03/25/2008 | CA2275153C Pharmaceutical compositions for freeze drying |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2173319C Radiation sensitization using texaphyrins |
| 03/21/2008 | CA2560409A1 Herbal product comprising cinnamon and bitter melon |
| 03/20/2008 | WO2008033239A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 03/20/2008 | WO2008033058A2 Method for producing insulin in the form of an oral preparation |
| 03/20/2008 | WO2008032767A1 Orally disintegrating tablet and process for production thereof |
| 03/20/2008 | WO2008032726A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
| 03/20/2008 | WO2008032719A1 Adhesive preparation |
| 03/20/2008 | WO2008032718A1 Adhesive preparation |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008032432A1 Gel type enteric nutrient |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031612A1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 03/20/2008 | WO2008031525A1 Hyaluronic acid derivatives obtained via 'click chemistry' crosslinking |
| 03/20/2008 | WO2008031465A1 Nano-vehicle for the transcutaneous transport, preparation containing the same and its use |
| 03/20/2008 | WO2008031286A1 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof |
| 03/20/2008 | WO2008031285A1 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 03/20/2008 | WO2008031188A1 Vitamin d compositions and method of administration to a human being |
| 03/20/2008 | WO2008031182A1 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 03/20/2008 | WO2008013822A3 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 03/20/2008 | WO2008012102A3 Radiodense conjugate |
| 03/20/2008 | WO2008010223A3 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 03/20/2008 | WO2008008857A3 Thiolated macromolecules and methods of making and using thereof |
| 03/20/2008 | WO2008003750A3 New protein conjugates and methods for their preparation |
| 03/20/2008 | WO2007135224B1 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 03/20/2008 | WO2007123771A3 Ige directed dna vaccination |
| 03/20/2008 | WO2007115724A3 Method of increasing the in vivo recovery of therapeutic polypeptides |
| 03/20/2008 | WO2007109354A3 Peptide-peptidase inhibitor conjugates and methods of using same |
| 03/20/2008 | WO2007104422A3 Agent-enriched nanoparticles based on hydrophilic proteins |
| 03/20/2008 | WO2007100563A3 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 03/20/2008 | WO2007060116A3 Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups |
| 03/20/2008 | WO2007052076A3 Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 03/20/2008 | WO2007048599A3 Drug-delivery systems |
| 03/20/2008 | WO2007042775A3 Conjugates of photosensitisers and antibodies |
| 03/20/2008 | WO2005044224A3 Drug delivery system based on polymer nanoshells |
| 03/20/2008 | WO2000074709A3 Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071068 Cytoplasmic Localization Dna and Rna |
| 03/20/2008 | US20080070994 Fibers and Nonwovens from Plasticized Polyolefin Compositions |
| 03/20/2008 | US20080070993 Additives for cosmetic products and the like |
| 03/20/2008 | US20080070992 Method for preparing solubilized composition containing oil-soluble substance |
| 03/20/2008 | US20080070981 Water-soluble compositions of bioactive lipophilic compounds |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070786 An addition condensation copolymer with thioether linkage for using in tissue engineering as cell scaffolds, biopolymers |
| 03/20/2008 | US20080070300 Human chemotactic cytokine |
| 03/20/2008 | US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery |
| 03/20/2008 | US20080069913 Anti-Snoring Composition |
| 03/20/2008 | US20080069902 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 03/20/2008 | US20080069894 Drug delivery; mixture of reaction product of dextran, dihydrazide and active material; pH adjustment; forming in situ |
| 03/20/2008 | US20080069891 Abuse resistant drug formulation |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/20/2008 | US20080069885 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/20/2008 | US20080069883 Applying to body tissue; adjust circulation; mixture containing penetration intensifiers, polymeric thickener, lipophic compound , water and buffer |
| 03/20/2008 | US20080069882 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
| 03/20/2008 | US20080069881 Abuse-resistant controlled-release opioid dosage form |
| 03/20/2008 | US20080069878 Mixture of drug with mixture of water insoluble polymer and enteric polymer coating |
| 03/20/2008 | US20080069875 Mixture of active material and graft polymers of polyvinyl alcohol and |
| 03/20/2008 | US20080069873 Controlled release system and method for manufacturing the same |
| 03/20/2008 | US20080069871 Hydrophobic abuse deterrent delivery system |
| 03/20/2008 | US20080069868 Irinotecan Preparation |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069865 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 03/20/2008 | US20080069864 Dispersed or encapsulated with a polymer matrix; low temperature meltig releases the cosmetics to skin |
| 03/20/2008 | US20080069861 Gastrointestinal health |
| 03/20/2008 | US20080069860 Administering a rare earth compound with calcium and aluminum salt or hydrophilic exchange resin in foods |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069844 Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component |
| 03/20/2008 | US20080069793 Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 03/20/2008 | US20080066744 Process for producing metered dose inhaler formulations |
| 03/20/2008 | DE102006040772A1 Polymermatrix, Verfahren zu deren Herstellung sowie deren Verwendung Polymer matrix, process for their preparation and their use |
| 03/20/2008 | DE10120092B4 Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung Gastro-resistant device for releasing of mucoadhesive drug carriers and procedures for preparing the enteric device |
| 03/20/2008 | DE10080167B4 Medikament zur Hemmung der Expression eines vorgegebenen Gens Medicament for inhibiting the expression of a given gene |
| 03/20/2008 | CA2663451A1 Rapidly disintegrating tablets in buccal cavity and manufacturing method thereof |
| 03/20/2008 | CA2663300A1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 03/20/2008 | CA2662938A1 Light-stable solid pharmaceutical composition of ramosetron |
| 03/20/2008 | CA2662924A1 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking |
| 03/20/2008 | CA2662799A1 Method for producing insulin in the form of an oral preparation |
| 03/20/2008 | CA2661892A1 Gel type enteral nutrient |
| 03/19/2008 | EP1900380A1 Pharmaceutical composition for vascular occlusive disease |
| 03/19/2008 | EP1900379A2 Method for the selective and quantitative functionalization of immunoglobulin FAB fragments, conjugate compounds obtained with the same and composition thereof |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1900368A1 Tablet containing hardly soluble active ingredient |
| 03/19/2008 | EP1900357A2 Drug delivery system for hydrophobic drugs |
| 03/19/2008 | EP1900283A2 Encapsulation of components into edible products |